Rtw Investments as of June 30, 2019
Portfolio Holdings for Rtw Investments
Rtw Investments holds 52 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rocket Pharmaceuticals (RCKT) | 13.3 | $249M | 17M | 15.00 | |
| Alnylam Pharmaceuticals (ALNY) | 8.5 | $160M | 2.2M | 72.56 | |
| Ptc Therapeutics I (PTCT) | 7.5 | $141M | 3.1M | 45.00 | |
| Dicerna Pharmaceuticals | 5.2 | $97M | 6.2M | 15.75 | |
| Stoke Therapeutics (STOK) | 4.9 | $93M | 3.4M | 27.59 | |
| Sarepta Therapeutics (SRPT) | 4.9 | $92M | 604k | 151.95 | |
| Milestone Pharmaceuticals (MIST) | 4.9 | $91M | 3.5M | 25.83 | |
| Adverum Biotechnologies | 4.0 | $75M | 6.3M | 11.89 | |
| Bristol Myers Squibb (BMY) | 3.8 | $71M | 1.6M | 45.35 | |
| Axonics Modulation Technolog (AXNX) | 3.4 | $63M | 1.5M | 40.97 | |
| Masimo Corporation (MASI) | 3.0 | $55M | 372k | 148.82 | |
| Vericel (VCEL) | 2.6 | $49M | 2.6M | 18.89 | |
| Establishment Labs Holdings Ord (ESTA) | 2.2 | $41M | 1.9M | 21.99 | |
| Homology Medicines | 2.1 | $40M | 2.1M | 19.57 | |
| Achillion Pharmaceuticals | 2.0 | $37M | 14M | 2.68 | |
| Myokardia | 1.9 | $36M | 724k | 50.14 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 1.8 | $34M | 3.7M | 9.10 | |
| Translate Bio | 1.6 | $31M | 2.4M | 12.63 | |
| Agenus | 1.6 | $30M | 10M | 3.00 | |
| Illumina (ILMN) | 1.6 | $30M | 82k | 368.15 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.6 | $30M | 1.1M | 26.50 | |
| Mirati Therapeutics | 1.4 | $26M | 255k | 103.00 | |
| D Fluidigm Corp Del (LAB) | 1.4 | $26M | 2.1M | 12.32 | |
| Apyx Medical Corporation (APYX) | 1.2 | $23M | 3.4M | 6.72 | |
| Axsome Therapeutics (AXSM) | 1.2 | $22M | 844k | 25.75 | |
| Regenxbio Inc equity us cm (RGNX) | 1.0 | $19M | 368k | 51.37 | |
| La Jolla Pharmaceuticl Com Par | 1.0 | $19M | 2.0M | 9.25 | |
| Arvinas Ord (ARVN) | 0.9 | $18M | 808k | 21.99 | |
| Transmedics Group (TMDX) | 0.8 | $15M | 507k | 28.99 | |
| Orthopediatrics Corp. (KIDS) | 0.8 | $15M | 377k | 39.00 | |
| Quotient | 0.8 | $14M | 1.5M | 9.35 | |
| Johnson & Johnson (JNJ) | 0.7 | $13M | 94k | 139.28 | |
| Odonate Therapeutics Ord | 0.7 | $12M | 339k | 36.69 | |
| Arbutus Biopharma (ABUS) | 0.6 | $12M | 5.5M | 2.08 | |
| Uniqure Nv (QURE) | 0.6 | $11M | 145k | 78.15 | |
| Cytomx Therapeutics (CTMX) | 0.6 | $11M | 988k | 11.22 | |
| Silk Road Medical Inc Common | 0.6 | $11M | 224k | 48.46 | |
| Myriad Genetics (MYGN) | 0.6 | $11M | 377k | 27.78 | |
| Principia Biopharma | 0.5 | $9.0M | 271k | 33.19 | |
| Chardan Healthcare Acquisition | 0.3 | $6.1M | 600k | 10.19 | |
| Brainsway Ltd- (BWAY) | 0.3 | $6.3M | 597k | 10.49 | |
| Personalis Ord (PSNL) | 0.3 | $6.1M | 225k | 27.15 | |
| Caredx (CDNA) | 0.3 | $5.6M | 155k | 35.99 | |
| Argenx Se (ARGX) | 0.2 | $4.5M | 31k | 141.57 | |
| Motus Gi Hldgs Incorporated | 0.2 | $3.4M | 1.1M | 3.03 | |
| Vivus Inc conv | 0.2 | $3.1M | 4.0M | 0.78 | |
| Neuronetics (STIM) | 0.1 | $2.1M | 168k | 12.51 | |
| Viveve Med | 0.1 | $1.7M | 4.5M | 0.38 | |
| Viewray (VRAYQ) | 0.1 | $1.4M | 159k | 8.81 | |
| Solid Biosciences | 0.0 | $835k | 145k | 5.75 | |
| Optinose (OPTN) | 0.0 | $620k | 88k | 7.08 | |
| Anchiano Therapeutics | 0.0 | $233k | 52k | 4.49 |
